AwardedNetherlandsGoods
NULISA technologie
- Published
- Published 2 December 2025
Overview
Stichting Amsterdam UMC procured NULISA technology from Alamar Biosciences Europe SRL, an ultrasensitive protein analysis platform for measuring brain-specific proteins relevant to neurological disorders in blood and cerebrospinal fluid. The technology enables simultaneous measurement of multiple proteins in small sample volumes with ease of use, supporting clinical research and treatment development for neurological conditions. The award was completed on 26 November 2025 for a nominal value of 1 EUR.
Key details
- Country
- Netherlands
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 2 December 2025
Biochemical analysers
Award outcome
- Awarded value
- €1
- Award date
- 26 November 2025
- Contract period
- — → 26 October 2031
- alamar biosciences Europe SRL
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
30 January 2026
Contract Notice
2 December 2025
Contracting authority
Stichting Amsterdam UMC
Procuring entityAMSTERDAM, Netherlands
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.